Thyrotrophin receptor antibody concentration and activity, several years after treatment for Graves’ disease

Summary Objective TSH receptor antibodies (TRAb) are responsible for autoimmune hyperthyroid disease (Graves’ disease; GD) with TRAb levels tending to decrease following treatment. Measurement of TRAb activity during follow‐up could prove valuable to better understand treatment effectiveness. Study...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Clinical endocrinology (Oxford) Ročník 90; číslo 2; s. 369 - 374
Hlavní autoři:	Nalla, Preethi, Young, Stuart, Sanders, Jane, Carter, Joanne, Adlan, Mohamed A., Kabelis, Katarzyna, Chen, Shu, Furmaniak, Jadwiga, Rees Smith, Bernard, Premawardhana, Lakdasa D. K. E.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Wiley Subscription Services, Inc 01.02.2019
Témata:	Adult Autoantibodies - blood Carbimazole - therapeutic use Female Graves Disease - etiology Graves Disease - immunology Graves Disease - surgery Graves Disease - therapy Graves' disease Graves’ disease treatment Humans Iodine Radioisotopes - therapeutic use Male Middle Aged Patients Receptors, Thyrotropin - immunology Surgery thyrotrophin receptor antibodies Time Factors Graves’ disease treatment thyrotrophin receptor antibodies
ISSN:	0300-0664, 1365-2265, 1365-2265
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!